Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-03-22
2011-03-22
Gussow, Anne M. (Department: 1643)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500
Reexamination Certificate
active
07910711
ABSTRACT:
The invention discloses a human cancer-related gene, LAPTM4B, its encoded products and their applications thereof. This human cancer-related gene provided by this invention comprises one of the following nucleotide sequences: (1) SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings; (2) Polynucleotides that encode the protein sequences of SEQ ID No: 4, SEQ ID No: 5, or SEQ ID No: 7 in the sequence listings; (3) DNA sequences having above 90% homology with the DNA sequences specified by SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings, and these DNA sequences encode the proteins with the same or similar functions. This invention enables the developments of new anti-cancer approaches and new anti-cancer medicines. It would create a significant impact on human society.
REFERENCES:
patent: 6465620 (2002-10-01), Boyle et al.
patent: 2005/0259483 (2005-11-01), Nakamura et al.
patent: WO 91/09045 (1991-06-01), None
patent: WO 00/05367 (2000-02-01), None
patent: WO/00/05367 (2000-02-01), None
patent: WO 0005367 (2000-02-01), None
patent: WO 01/12662 (2001-02-01), None
patent: WO 01/53312 (2001-07-01), None
patent: WO 02/059260 (2002-08-01), None
patent: WO 02/071928 (2002-09-01), None
patent: WO 2005/032495 (2005-04-01), None
patent: WO 2005/044990 (2005-05-01), None
Lewin, B. ed. Genes IV, Oxford University Press, 1990. p. 810.
Skolnick, J., and Fetrow, J.S. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotechnology, 2000. vol. 18, pp. 34-39.
Burgess, W.H., Shaheen, A.M., Ravera, M., Jaye, M., Donohue, P.J., and Winkles, J.A. Possible dissociation of the heparin-binding (acidic fibroblast) growth factor-1 from its receptor binding activities by site-directed mutagenesis of a single lysine residue. Journal of Cell Biology, 1990. vol. 111, pp. 2129-2138.
Lazar, E., Watanabe, S., Dalton, S., and Sporn, M.B. Transforming growth factor a: mutation of aspartic acid 47 and leucine 48 results in different biological activites. Molecular and Cellular Biology, 1988. vol. 8, pp. 1247-1252.
Schwartz, G.P., Burke, G.T., and Katsoyannis, P.G. A superactive insulin: [B10-Aspartic acid]insulin (human). Proceedings of the National Academy of Sciences, 1987. vol. 84, pp. 6408-6411.
Lin, M.C., Wright, D.E., Hruby, V.J., and Rodbell, M. Structure-function relationships in glucagon: properties of highly purified Des-His1- Monoiodo-, and [Des-Asn28, Thr29](homoserine lactone27)glucagon. Biochemistry, 1975. vol. 14, pp. 1559-1563.
Genbank accession No. AAP14034, submitted Aug. 11, 2003.
Genbank accession No. AAO84265, submitted Apr. 21, 2003.
Genbank accession No. AY198226, submitted Aug. 11, 2003.
Pennica et al. Proc. Natl. Acad. Sci. USA, 95:14717-14722, 1998.
Konopka et al. Proc. Natl. Acad. Sci. USA, 83:4049-4052, 1986.
Chen et al. Molecular and Cellular Proteomics 1:304-313, 2002.
Hu et al. Journal of Proteome Research 2(4):405-412, 2003.
Haynes et al. Electrophoresis 19:1862-1871, 1998.
Gygi et al. Mol. Cell. Biol. 19:1720-1730, 1999.
Lian et al. Blood 98:513-524, 2001.
Fessler et al. The Journal of Biological Chemistry. 277:31291-31302, 2002.
Hanash S. Nature Reviews, Applied Proteomics Collection, pp. 9-14, Mar. 2005.
LaBaer J. Nature Biotechnology 21:976-977, 2003.
Acland, Dixon, Peters, and Dickson. Subcellular fate of the Int-2 oncoprotein is determined by choice of initiation codon. Nature, 1990. vol. 343, pp. 662-665.
Accession No. AY057051 NCBI. http://www.ncbi.nlm.nih.gov
uccore/AY057051 as retrieved Apr. 15, 2010.
Wiemann, et al. Genome Research, 2001. vol. 11, pp. 422-435.
Gen-Ze Shao et al., Molecular cloning and characterization ofLAPTM4B, a novel gene upregulated in hepatocellular carcinoma, 2003, pp. 5060-5069.
Mammalian Gene Collection (MGC) Program Team, Strausberg et al., Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences, Proceedings of the National Academy of Sciences of the U.S.A., Dec. 24, 2002, vol. 99 No. 26. pp. 16899-16903.
Grit Kasper et al., The human LAPTM4b transcript is upregulated in various types of solid tumours an seems to play a dual functional role during tumor progression, Cancer Letters Aug. 8, 2004, vol. 224, No. 1, pp. 93-103.
Database Geneseq [Online] Oct. 22, 2001, Human Polypeptide SEQ ID No. 2720. XP002372228, retrieved from EBI accession No. GSP:AAM39575, Database accession No. AAM39575.
Database Geneseq [Online] Oct. 22, 2001, Human Polypeptide SEQ ID No. 2720. XP002372229, retrieved from EBI accession No. GSP:AAI58731, Database accession No. AAI58731.
Database EMBL [Online] Oct. 30, 2001,Homo sapiensLysosomal Associated Transmembrane Protein 4 Beta, Variant 1 (LAPTM4B) mRNA, complete cds. XP002372230, retrieved from EBI accession No. EM—HUM:AY057051, Database accession No. AY057051.
Database EMBL [Online] Nov. 1, 2002,Homo sapiensLysosomal Associated Protein Transmembrane 4 Beta, mRNA (cDNA clone MGC:43257 IMAGE:5264567), complete cds. XP002372231 , retrieved from EBI accession No. EM—HUM:BC038117, Database accession No. BC038117.
Database Geneseq [Online] Feb. 25, 2003, Human Protein SEQ ID No. 364. XP002372232, retrieved from EBI accession No. GSP:ABP64704, Database accession No. ABP64704.
Database EMBL [Online] Mar. 1, 2001,Homo sapiensGenomic DNA, chromosome 8q23, clone: KB1907C4. XP002372233, retrieved from EBI accession No. EM—HUM:AP003357, Database accession No. AP003357.
Arvanitis et al. “Conditional transgenic models define how MYC initiates and maintains tumorigenesis” Seminars in Cancer Biology, 16 (2006): 313-317.
Cheng et al. “Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers” Ann. Oncol., 2008, 19(3): 527-532.
Deng et al. “Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer”, Beijing Da Xue Xue Bao, 2005, 37(3):302-305. Abstract.
Hanahan et al. “The hallmarks of cancer.” Cell, 2000, 100(1): 57-70.
He et al. “Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells” J. Peking University (Health Sciences), 2003, 35(4): 348-352.
Liu et al. “Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma”, World J, Gastroenterol, 2004, 10(11): 1555-1559.
Liu et al. “Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer” Ann. Oncol., 2007, 18(2): 311-316.
Pelengaris et al. “c-MYC: more than just a matter of life and death”, Nat. Rev. Cancer, 2002, 2(10):764-776.
Peng et al. “Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.”, World J. Gastroenterol. 2005, 11 (18): 2704-2708.
Shachaf et al. “MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer” Nature, 2004, 431(7012): 1112-1117.
Yang et al. “LAPTM48 overexpression is an independent prognostic marker in ovarian carcinoma”, Oncology Reports, Jul. 2008, accepted.
Zhou et al. “Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma”, European Journal of Cancer, 43 (4): 809-815.
Zhou et al. “Expression of LAPTM4B-35: A novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma”, Cancer Letter, 264(2): 209-217.
Zhou et al. “LAPTIM4B, a hepatocellular carcinoma-associated novel proto-oncogene”, Falk Symposium 150, Berlin, 2005.10, Abstract p. 121 and poster prized by the conference.
Zhou et al. “LAPTM4B, A Novel Cancer Target (II)”, The 3rd International Congress of Cancer progression, Baltimore, 2006, Abstract, p
Jin Yueying
Lin Ming
Liu Xinrong
Rui Jingan
Shao Genze
Gussow Anne M.
McKenna Long & Aldridge LLP
Peking University
LandOfFree
Human cancer-relating genes, the products encoded thereby... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human cancer-relating genes, the products encoded thereby..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human cancer-relating genes, the products encoded thereby... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2625580